AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05229354 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: TV005
Description: The TV005 admixture is comprised of four monovalent dengue vaccine candidates representing each of the four DENV serotypes: rDEN1Δ30, rDEN2/4Δ30(ME), rDEN3Δ30/31, and rDEN4Δ30.
Study NCT05229354 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: rDEN2Δ30-7169 attenuated virus strain
Description: based on a cDNA derived DENV-2 virus (strain Tonga/74) in which the 3´ UTR of DENV-2 contains a 30 (nt) deletion (nt 173 - 143) homologous to the ∆30 deletion in the 3´ UTR of rDEN4Δ30 (named Δ30 for consistency). A plasmid was constructed to encode the entire genome of DENV-2 Tonga/74. The cDNA of the 3´ UTR of DENV-2 Tonga/74 was then modified to introduce a 31-nucleotide deletion homologous to the DEN4Δ30 deletion (∆30). Genome-length, capped, RNA transcripts were synthesized from the plasmid p2Δ30-7169 and purified
Study NCT05101161 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Neurofeedback
Description: Modulating brain oscillations based on visual neurofeedback
Study NCT05898334 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active Biophoton Generators
Description: The whole body, including brain, of the study participant will be sleeping inside of the strong biophoton field so her/his entire body will be energized to promote self-healing.
Study NCT05898334 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Inactive Biophoton Generators
Description: The whole body, including brain, of the study participant will be sleeping inside of the normal hotel bed and the participant will not receive any biophotons.
Study NCT05202977 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SinocrownTM Transcatheter Aortic Valve Replacement System
Description: Subjects receiving SinocrownTM Transcatheter Aortic Valve Replacement System of Lepu Medical
Study NCT05409976 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GORE® VIAFORT Vascular Stent
Description: Treatment of symptomatic IVC obstruction with or without combined iliofemoral obstruction with the GORE® VIAFORT Vascular Stent.
Study NCT05476549 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lemon verbena
Description: Lemon verbena supplement administered at an estimated daily dose of 15mg/kg
Study NCT05476549 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo supplement containing carrier material only
Study NCT01784510 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: distance of dissection of gastrocolic ligament from pylorus
Study NCT01784510 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: distance of dissection of gastrocolic ligament from pylorus
Study NCT06082817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oral Testosterone Undecanoate
Description: 50mg oral testosterone undecanoate daily
Study NCT05967416 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: SIRPant-M
Description: Autologous activated macrophage cell therapy manufactured from peripheral blood mononuclear cells given by intratumoral injection
Study NCT05967416 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: External-beam radiotherapy (XRT)
Description: Radiotherapy given by external beam to the IT-injected lesion only
Study NCT06745570 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Lifestyle Modification and Sleep Intervention
Description: This study is being performed to develop, refine, and test the effects of a group lifestyle modification intervention augmented with a sleep intervention on weight loss, eating behaviors, and sleep outcomes. Results from this study will inform future studies to test the efficacy of this intervention. This intervention is being offered as part of a research study within Drexel University's WELL Center. Participants will receive remote, group-based, weekly weight loss and sleep coaching (90 minutes per coaching session) for 16 weeks.
Study NCT04892147 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mobility-Oriented Behavioral Activation
Description: 12-weeks of mobility-oriented behavioral activation group
Study NCT04892147 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Mobility-Oriented Behavioral Activation
Description: 12-weeks of mobility-oriented behavioral activation group
Study NCT04745234 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mogamulizumab
Description: For the first 28-day induction cycle (C1), mogamulizumab 1 mg/kg will be administered as an IV infusion through a 0.22- or 0.2-μm in-line filter over at least 60 minutes on Days 1, 8, 15, and 22.~For all subsequent 28-day cycles (C2, 3, 4, etc.), mogamulizumab 2 mg/kg will be administered as an IV infusion over at least 60 minutes on Day 1 of each subsequent therapy cycle.
Study NCT06729762 — intervention group
Intervention type: PROCEDURE
Intervention: ultrasound-guided thermal ablation
Description: radiofrequency ablation, microwave ablation, laser ablation
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 10mg
Description: DWP212525 10mg
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 30mg
Description: DWP212525 30mg
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 50mg
Description: DWP212525 50mg
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 100mg
Description: DWP212525 100mg
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 200mg
Description: DWP212525 200mg
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 400mg
Description: DWP212525 400mg
Study NCT06736587 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DWP212525 placebo
Description: DWP212525 placebo
Study NCT06740500 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: probiotic sachet mainly contains Bifidobacterium animalis subsp. lactis Bi66 and maltodextrin.
Study NCT06740500 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Maltodextrin
Study NCT06742437 — intervention group
Intervention type: DEVICE
Intervention: Standard sperm preparation
Description: Sperm samples in the control group will undergo traditional processing
Study NCT06742437 — intervention group
Intervention type: DEVICE
Intervention: HyperSperm
Description: Sperm samples in the experimental group will undergo product-specific processing
Study NCT06738589 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: non-invasive ventilation
Description: Non-invasive ventilation adds positive pressure to the upper airway via a mask on the face.
Study NCT06740539 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Catheter ablation of atrial fibrillation
Description: Catheter ablation of atrial fibrillation
Study NCT06759493 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Retinol isotope dilution technique
Description: A group of 60 school children will be recruited through a stratified sampling. To this first group of 60 school children a retinol isotope dilution (RID) test for total body store assessment will be applied. The remaining 98 school children will be recruited according to stratified sampling and divided into two groups of 49 children (females and males). To these groups of children, the modified relative dose response (MRDR) test, a qualitative measure of vitamin A status will be used to investigate the absorption of 3,4-didehydroretinyl acetate in oil.
Study NCT05366933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vitamin B-Complex Supplement
Description: Vitamin B-Complex Supplement containing: 5-methyltetrahydrofolate, riboflavin 5 phosphate, pyridoxal phosphate, and methylcobalamin
Study NCT05805969 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Accommodating variable-resistance training
Description: The training was conducted twice weekly for six successive weeks under the close supervision of a licensed pediatric physical therapist in accordance with the safety performance guidelines defined by the American Academy of Pediatrics and the US National Strength and Conditioning Association.~The training protocol included maximum voluntary concentric knee flexor/extensor actions. Three sets of five to 10 repetitions of maximum-effort concentric action at angular speeds of 240, 180, and 120 degrees/second.~The training started with a 10-minute warm-up exercise and ended up with a 5-minute cool-down exercise.
Study NCT05805969 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard physical therapy
Description: The program encompassed the standard exercises for patients with juvenile idiopathic arthritis (aerobic, weight-bearing, proprioceptive, flexibility, and strengthening exercises). The training was conducted for 45 minutes, two times a week for six successive weeks.
Study NCT06771297 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: nursing education
Description: Nursing training will be given before rhinoplasty surgery. As a result, patients' involuntary thoughts and quality of recovery will be questioned.
Study NCT06771297 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: nursing education
Description: Nursing training will be given before rhinoplasty surgery. As a result, patients' involuntary thoughts and quality of recovery will be questioned.
Study NCT06771804 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Cricket Protein
Description: Participants are provided with muffins containing either whey or cricket protein.
Study NCT06771804 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cricket Protein
Description: Participants are provided with muffins containing either whey or cricket protein.
Study NCT06777849 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Right to Play-Plus (RTP-Plus)
Description: The comprehensive curriculum comprises of themes: Social and Emotional Development and Sexual and Reproductive Health will be delivered by school teachers who will receive training from Right to Play and Aahung. There will be 60 sessions for two years.
Study NCT06777849 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Control
Description: There will be no intervention given to control arm during two years of cluster randomised control trial (cRCT). However, a delayed intervention having teachers' training, will be provided to the control arm after the completion of endline for the duration of 3-4 months.
Study NCT06781749 — intervention group
Intervention type: DEVICE
Intervention: Hearing aid use
Description: Hearing aid use will be discussed with all eligible participants with hearing loss and will be encouraged to pursue hearing aid fitting through standard clinical indications via participants' insurance and audiologists.
Study NCT04497220 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Negative Connotation Langauge
Description: The study intervention consists of two separate scripts read to the patient by the anesthesiologist performing their labor epidural. The control script includes language containing the wording Poke and a burn said prior to numbing medication for the epidural procedure. There will be no difference in the epidural placement, medications, or the rest of the script.
Study NCT04497220 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Connotation Language
Description: The study intervention consists of two separate scripts read to the patient by the anesthesiologist performing their labor epidural. The experimental script includes language containing the wording this is numbing medication, which will make the rest of the procedure go easier said prior to numbing medication for the epidural procedure. There will be no difference in the epidural placement, medications, or the rest of the script.
Study NCT06780566 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Point-of-care PCR testing for respiratory viruses
Description: A nasal swab will be collected by trained research staff in full personal protective equipment (PPE) and placed into 3 mL of viral transport medium. The sample will be immediately processed and analysed in the ED using the Xpert® Xpress SARS-CoV-2/Flu/RSV test according to the manufacturer's instructions. The results of the test will be documented in the patient's paper or electronic case notes, and the clinical team will be directly informed of all results. The participant or legal guardian who signs the consent form will also be informed of the results when appropriate.
Study NCT06780566 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Laboratory PCR testing for respiratory viruses
Description: The ordering of test for respiratory pathogens will be decided by the treating clinical team. All tests will be performed using the standard methods of the hospital laboratory.
Study NCT06781021 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Tourniquet
Description: In all cases the application of a pneumatic torniquet will be applied to the proximal thigh after induction of anesthesia but will not be inflated for the group receiving TXA.
Study NCT06781021 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: TXA
Description: In all cases the application of a pneumatic torniquet will be applied to the proximal thigh after induction of anesthesia but will not be inflated for the group receiving TXA.
Study NCT06780423 — intervention group
Intervention type: PROCEDURE
Intervention: Minimal invasive fine needle muscle biopsies
Description: Fine needle muscle biopsies will be taken from the m. erector spinae and the m. vastus lateralis. Participants are placed in a standardized prone position on the examination table for measurements of the m. erector spinae and in a supine position for measurements of the m. vastus lateralis.
Study NCT06782308 — intervention group
Intervention type: OTHER
Intervention: Survey using a questionnaire.
Description: patients preferences survey
Study NCT06772688 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: orthognathic surgery
Description: Maxillary repositioning and fixation with custom made plate
Study NCT06781827 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotic
Description: The experimental phase of the study lasts 8 weeks and each patient will be visited 4 times (January, March, June, and December).
Study NCT06781827 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Maltodextrin
Description: The experimental phase of this study had last 8 weeks and each patient will make 4 visits (January, March, June, and December).
Study NCT06745479 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Emotion Upregulation
Description: Participants will identify personal goals or activities that they would like to engage in more and describe these goals/activities in a written format with research staff. Participants will then complete a gambling task during functional MRI scanning. Prior to making some gambling decisions, participants are instructed to mentally imagine achieving a goal or engaging in an enjoyable activity. Prior to the other decisions participants are instructed to respond naturally (i.e., not use the cognitive strategy).
Study NCT06745102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Xanthohumol
Description: Participants receive a study drink supplemented with Xanthohumol (0 mg = Placebo or 0.75 mg soluble Xanthohumol)
Study NCT06745102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Iso-alpha Acids
Description: Participants receive a study drink supplemented with Iso-alpha Acids (0 mg = Placebo or 45 mg Iso-alpha Acids)
Study NCT06745102 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Xanthohumol + Iso-alpha Acids
Description: Participants receive a study drink supplemented with Xanthohumol and Iso-alpha Acids (0 mg = Placebo or 0.75 mg + 45 mg soluble Xanthohumol + Iso-alpha Acids)
Study NCT06744322 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Fast discharge strategy
Description: Patients undergoing invasive management after myocardial infarction will be discharged after 24 (+/- 12) hours.
Study NCT06745934 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Healthy Minds Program
Description: Participants in this arm engage with the Healthy Minds Program app/
Study NCT06743867 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pressurized Intraperitoneal Aerosol Chemotherapy
Description: The comprehensive therapeutic strategy will be modified based on the integrated 2- or 3-week systemic chemotherapies. In the interim, a total of three PIPAC procedures will be conducted for all qualifying patients.~1. PIPAC combined with 2-week systemic chemotherapies:~   PIPAC therapy will occur every four weeks, while systemic chemotherapies will be administered during the first and third weeks following the initial and second PIPAC procedures respectively.~2. PIPAC combined with 3-week systemic chemotherapies:~(1) Scheme 1: PIPAC therapy will occur every 6 weeks, with systemic chemotherapies administered during the 1st and 4th weeks following the first and second PIPAC procedures, respectively.~(2) Scheme 2: PIPAC therapy will occur every 6 weeks, while systemic chemotherapies will be administered in the 2nd and 5th weeks following the initial and second PIPAC procedures, respectively.
Study NCT06745713 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Turkish- Computer System Usability Questionnaire Short Version
Description: Developed in 1995 by Lewis at IBM, the Computer System Usability Questionnaire (CSUQ) is one of the widely used questionnaires in the field of usability. The scale, which was adapted into Turkish by Erdinç in 2013, consists of 13 items in total. It has 4 sub-dimensions: system usefulness (items 1-6), information quality (items 7-9), interface quality (items 10-12) and general satisfaction (item 13). Each item is scored as 1 (Strongly agree) - 7 (Strongly disagree). The Cronbach α of the scale is > .70 and the Cronbach α value for each sub-dimension varies between .73 and .92. A minimum score of 13 and a maximum score of 91 can be obtained from the scale. A low score is defined as good usability, and the higher the score, the lower the usability quality of the system (Erdinç \& Lewis, 2013).
Study NCT06745713 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Student Information Form
Description: In the form developed by the researchers in line with the literature, a total of 12 questions were included to determine the socio-demographic characteristics of the students (such as age, gender, academic average, whether they provide care to patients with chest tubes, whether they receive training on chest tube care). All participants in the experimental and control groups were applied once as a pre-test.
Study NCT06780982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Balloon-Blowing exercise program
Description: he program begins with a one-on-one session on the first day of the research project and continues with home-based care through the LINE application on a smartphone for 5 weeks. The program consists of four steps:~1. Decision-Making in Self-Care~2. Setting Goals and Planning Self-Care~3. Self-Care Implementation: practicing the balloon-blowing exercise daily for 3 sets of 3 balloons per set (a total of 9 balloons/day), with a 1-minute rest between sets, over a period of 5 weeks.~4. Maintaining Self-Care Behaviors
Study NCT06780982 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard nursing care
Description: The actions of nurses towards school-age children with obstructive sleep apnea at the hospital involve screening patient records and distributing educational materials in the form of brochures to individual pediatric patients and their parents. The knowledge provided in the brochures includes instructions on how to administer inhaled medication, avoiding allergens, performing facial and neck muscle exercises, and attending follow-up appointments as scheduled.
Study NCT06782126 — intervention group
Intervention type: BEHAVIORAL
Intervention: BreeZe (Brandwonden en Zelfmanagement)
Description: BreeZe is a self-management support program designed to enhance burn survivors' intrinsic motivation and self-efficacy for self-management after discharge. The intervention is based on the Self-Regulation Theory framework. Key strategies include evidence-based techniques such as goal setting and pursuit, Solution-Focused Brief Therapy, and Motivational Interviewing. The program takes a positive approach to boost motivation and self-efficacy, promoting sustainable behavior change in burn aftercare. BreeZe will be implemented through various strategies, including educating healthcare professionals on self-management, training them in communication skills (e.g., motivational interviewing), and providing materials such as a decision aid tool (self-management web) and a workbook tailored to burn survivors. Burn survivors will use the web to identify and prioritize problems, set personalized goals with their healthcare professional, and create an action plan for goal attainment.
Study NCT06780540 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Operation Alert: Support prgram
Description: Substudy 1:~Testing of a newly developed psycho-education tool will occur across four partner hospitals and participating nonprofit organizations (NGOs). Victims of violence seeking care at these sites will receive immediate support, with the pilot study integrated into standard care practices. The psycho-education toolkit enhances the foundational care already provided. The tool supports healthcare providers in offering psycho-education about e.g. violence and (the effects) of trauma, ...~Substudy 2:~This pilot study evaluates the Operation Alert guidelines within the geriatrics departments of four hospitals. A geriatric assessment is standard care during admission to these departments. The pilot will be embedded into this existing practice to ensure alignment with routine care. Additional questions will be embedded in a geriatric assessment/intake focusing on older adults' well-being, relationships and social network, and potential life events (e.g. experiences of violence).